We are currently testing fixes to the following bugs: Ignores, Inbox Folder Access, Hide Replies, View Thread & a few others. It's taking a little longer than we had hoped, but we expect to push out corrected code this Friday night. We apologize for the delay & appreciate your continued patience. Stay tuned for further updates.
This is a semi-private group. You are free to browse messages, but you must be a member of this group to post messages. Join This Group
I thought it was fine. Nothing really new, but a couple of points I liked:
1) They expressed strong feelings that lympho would be approved and that they/Cardinal are gearing up. 2) It seems that there could be Euro distributor info coming in the not too distant future, and that terms could be very good. 3) Their take on short interest, we are aware, but really only concerned with executing the business plan. 4) Big Pharma is seeking them out to help because of their expertise in getting products through late trials/regulatory (hard to believe after troubles we have had in the past, but a new sheriff is in town now)
I think they are focused on really moving the business forward. I don't think they are worried about getting the share price up a few bucks on the short term; they see much bigger things long term.
